Publications by authors named "Robert Redner"

Claim this Profile
Z
Ziftomenib in Relapsed or Refractory -Mutated AML.
Eunice S Wang, Pau Montesinos, James Foran, Harry Erba, Eduardo Rodríguez-Arbolí, Robert L Redner

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.
Eric D Eisenmann, Ronan Swords, Ying Huang, Shelley Orwick, Daelynn Buelow, Robert Redner

Cancer Res Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.
Fieke W Hoff, Ying Huang, Rina Li Welkie, Ronan T Swords, Elie Traer, Robert L Redner

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.
Kevin Quann, Konstantinos Lontos, Alison Sehgal, Anastasios Raptis, Annie Im, Robert L Redner

Haematologica· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.
Fieke W Hoff, William G Blum, Ying Huang, Rina Li Welkie, Ronan T Swords, Robert L Redner

Blood Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.
Annie Im, Kevin Quann, Mounzer Agha, Anastasios Raptis, Robert L Redner

Am J Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Vu H Duong, Amy S Ruppert, Alice S Mims, Uma Borate, Eytan M Stein, Robert L Redner

Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Robert L Redner

Leuk Lymphoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Robert L Redner

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.
Christi McKeown, Asha Ricciuti, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Robert L Redner

Support Care Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.
Arisha Patel, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner

Oncol Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The eyes have it: CNS leukemia presenting as optic neuritis.
Kevin A Quann, Robert L Redner

Int J Hematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.
Robert L Redner, Jan H Beumer, Patricia Kropf, Mounzer Agha, Michael Boyiadzis

Leuk Lymphoma· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Samir Mazharuddin, Anuja Chattopadhyay, Moshe Y Levy, Robert L Redner

Leuk Lymphoma· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.
Matthew J Lim, Aya Agha, Annie Im, Anastasios Raptis, Jing Z Hou, Robert L Redner

Hematol Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.
Michael Boyiadzis, Mounzer Agha, Robert L Redner, Alison Sehgal, Annie Im

Cytotherapy· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.
Konstantinos Lontos, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner

Clin Transplant· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse.
Annie Im, Ali Amjad, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Robert L Redner

Oncol Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemia.
Kelly Ross, Amanda L Gillespie-Twardy, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Robert L Redner

Oncol Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
Vipin Villgran, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner

Transfus Apher Sci· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPM-RAR binding to TRADD selectively inhibits caspase activation, while allowing activation of NFκB and JNK.
Anuja Chattopadhyay, Irina Abecassis, Robert L Redner

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of acute myeloid leukemia with t(15;17) not associated with acute promyelocytic leukemia.
Amy Soni, Miroslav Djokic, Jing-Zhou Hou, Robert L Redner, Michael Boyiadzis

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.
Erin M Swaney, Anuja Chattopadhyay, Irina Abecassis, Elizabeth A Rush, Robert L Redner

Leuk Lymphoma· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ATRActive future for differentiation therapy in AML.
Daniel E Johnson, Robert L Redner

Blood Rev· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADD.
Anuja Chattopadhyay, Brian L Hood, Thomas P Conrads, Robert L Redner

Mol Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis